Characterization of PET/CT images using texture analysis: the past, the present… any future?

scientific article

Characterization of PET/CT images using texture analysis: the past, the present… any future? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/S00259-016-3427-0
P932PMC publication ID5283691
P698PubMed publication ID27271051

P50authorDimitris VisvikisQ91680418
Catherine Cheze Le RestQ47460846
P2093author name stringPaul E Kinahan
Larry Pierce
Mathieu Hatt
Catherine Cheze Le Rest
Florent Tixier
P2860cites workQuantification of Intratumoral Metabolic Macroheterogeneity on 18F-FDG PET/CT and Its Prognostic Significance in Pathologic N0 Squamous Cell Lung Carcinoma.Q52991547
Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer.Q53063662
Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.Q53068643
Novel spatial analysis method for PET images using 3D moment invariants: Applications to Parkinson's diseaseQ60767139
Texture analysis of CT-images for early detection of liver malignancyQ72009739
Combined PET/CT image characteristics for radiotherapy tumor response in lung cancerQ82586040
Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CTQ83082145
Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disordersQ83752916
Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal CancerQ86211155
The promise and limits of PET texture analysisQ87250885
Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysisQ87319243
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachQ23760721
Radiomics: extracting more information from medical images using advanced feature analysisQ23760733
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic ReviewQ24288664
How to make more published research trueQ24288766
Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated reviewQ26851424
State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETQ27694674
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingQ27860948
Quantifying tumour heterogeneity with CTQ28709424
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patientsQ30458538
Fractal analysis in radiological and nuclear medicine perfusion imaging: a systematic reviewQ30663295
A statistical measure of tissue heterogeneity with application to 3D PET sarcoma dataQ30819319
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image featuresQ30820677
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?Q33576007
The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptakeQ33597565
Development of a nomogram combining clinical staging with (18)F-FDG PET/CT image features in non-small-cell lung cancer stage I-IIIQ33617538
Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Q33669828
Correlation of intra-tumor 18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancerQ33753620
Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.Q51783790
FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.Q52886599
Quantitative assessment of tumor metabolism using FDG-PET imagingQ34088981
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancerQ34164634
18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohortQ34453471
Radiomics: Images Are More than Pictures, They Are DataQ34502075
The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.Q34510278
A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk ScoresQ34514621
Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients.Q34521659
Decoding global gene expression programs in liver cancer by noninvasive imagingQ34630291
Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancerQ34724752
Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcomeQ35089180
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.Q35108363
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesQ35151263
Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.Q35734154
Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature modelsQ35737796
Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinomaQ35756750
Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks.Q35768828
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics StudyQ35850871
Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standardsQ35915904
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis.Q35916957
Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer PatientsQ35940876
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variabilityQ35945509
Machine Learning methods for Quantitative Radiomic BiomarkersQ35960448
Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics ApproachQ36195557
Metrology Standards for Quantitative Imaging BiomarkersQ36336865
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer.Q36343075
Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineationQ36350466
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Q36421023
Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic FactorsQ36425348
Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung CancerQ36427534
Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancerQ36763115
Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept StudyQ36804482
Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.Q37180546
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and DelineationQ37230607
FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvementQ37522745
Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems.Q37633048
Development and evaluation of an open-source software package "CGITA" for quantifying tumor heterogeneity with molecular imagesQ37686674
Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.Q37697013
Quantifying heterogeneity in human tumours using MRI and PET.Q37977699
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysisQ38052001
Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.Q38271116
An update on novel quantitative techniques in the context of evolving whole-body PET imaging.Q38279627
IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics.Q38367229
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.Q38432601
Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applicationsQ38446606
Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancerQ38580483
Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR ImagingQ38794635
Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant MetastasisQ38798562
MAPS: A Quantitative Radiomics Approach for Prostate Cancer DetectionQ38956083
Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomasQ38980180
The age of reason for FDG PET image-derived indicesQ39065889
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.Q39666021
Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung CancerQ39929954
Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinomaQ40000698
Exploring the use of shape and texture descriptors of positron emission tomography tracer distribution in imaging studies of neurodegenerative diseaseQ40218040
Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET.Q40674955
The precision of textural analysis in (18)F-FDG-PET scans of oesophageal cancerQ40918671
Robust feature selection to predict tumor treatment outcomeQ41456435
The method and efficacy of support vector machine classifiers based on texture features and multi-resolution histogram from (18)F-FDG PET-CT images for the evaluation of mediastinal lymph nodes in patients with lung cancerQ41714333
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.Q41790286
Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters.Q42035081
Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessmentsQ42353561
Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET.Q42648185
Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinomaQ43753631
MR tissue characterization of intracranial tumors by means of texture analysis.Q43755407
Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomographyQ43952149
Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.Q45035123
Intratumoral metabolic heterogeneity of cervical cancerQ46433358
The International EQUATOR Network: enhancing the quality and transparencyof health care researchQ46466135
Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.Q47429122
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.Q50891696
Staging of cervical cancer based on tumor heterogeneity characterized by texture features on (18)F-FDG PET images.Q50897746
Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.Q50955765
A gradient-based method for segmenting FDG-PET images: methodology and validation.Q51026384
Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.Q51059595
Computer-aided staging of lymphoma patients with FDG PET/CT imaging based on textural information.Q51158529
An automatic method for accurate volume delineation of heterogeneous tumors in PET.Q51175504
Hybrid RGSA and Support Vector Machine Framework for Three-Dimensional Magnetic Resonance Brain Tumor Classification.Q51669590
P433issue1
P304page(s)151-165
P577publication date2016-06-06
P1433published inEuropean Journal of Nuclear Medicine and Molecular ImagingQ15708890
P1476titleCharacterization of PET/CT images using texture analysis: the past, the present… any future?
P478volume44